THE EFFECT OF FOOD AND CONCURRENT CHEMOTHERAPY ON THE BIOAVAILABILITY OF ORAL ETOPOSIDE

被引：34

作者：

HARVEY, VJ

SLEVIN, ML

JOEL, SP

JOHNSTON, A

WRIGLEY, PFM

机构：

[1] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND

[2] HACKNEY HOSP,LONDON,ENGLAND

[3] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 03期

关键词：

D O I：

10.1038/bjc.1985.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：363 / 367

页数：5

共 31 条

[1]

ARNOLD AM, 1979, CANCER CHEMOTH PHARM, V3, P71

[2]

BEVERIDGE T, 1976, BIOAVAILABILITY STUD

[3]

CAVALLI F, 1978, CANCER TREAT REP, V62, P473

[4] SMALL CELL-CARCINOMA OF THE LUNG [J].

COMIS, RL .

CANCER TREATMENT REVIEWS, 1982, 9 (03) :237-258

[5]

DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141

[6]

DINCALCI M, 1982, EORTC CANCER CHEMOTH, V4, P87

[7]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715

[8] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ETOPOSIDE IN PLASMA AND URINE [J].

HARVEY, VJ ;

JOEL, SP ;

JOHNSTON, A ;

SLEVIN, ML .

JOURNAL OF CHROMATOGRAPHY, 1985, 339 (02) :419-423

[9]

HARVEY VJ, 1984, BR J CLIN PHARM, V17, P204

[10]

ISSELL BF, 1982, CANCER CHEMOTH PHARM, V7, P73

← 1 2 3 4 →